Cargando…

Tumorigenic Factor CRIPTO-1 Is Immunolocalized in Extravillous Cytotrophoblast in Placenta Creta

CRIPTO-(CR)1 is a protein associated with tumorigenesis and metastasis. Here we demonstrate that CR-1 expression in normal and creta placentas is associated with various degrees of uterine invasion. Cytokeratin (CK) and CR-1 protein expression was visualized by immunohistochemical staining of formal...

Descripción completa

Detalles Bibliográficos
Autores principales: Bandeira, Carla Letícia, Urban Borbely, Alexandre, Pulcineli Vieira Francisco, Rossana, Schultz, Regina, Zugaib, Marcelo, Bevilacqua, Estela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4140153/
https://www.ncbi.nlm.nih.gov/pubmed/25165718
http://dx.doi.org/10.1155/2014/892856
_version_ 1782331480517640192
author Bandeira, Carla Letícia
Urban Borbely, Alexandre
Pulcineli Vieira Francisco, Rossana
Schultz, Regina
Zugaib, Marcelo
Bevilacqua, Estela
author_facet Bandeira, Carla Letícia
Urban Borbely, Alexandre
Pulcineli Vieira Francisco, Rossana
Schultz, Regina
Zugaib, Marcelo
Bevilacqua, Estela
author_sort Bandeira, Carla Letícia
collection PubMed
description CRIPTO-(CR)1 is a protein associated with tumorigenesis and metastasis. Here we demonstrate that CR-1 expression in normal and creta placentas is associated with various degrees of uterine invasion. Cytokeratin (CK) and CR-1 protein expression was visualized by immunohistochemical staining of formalin-fixed, paraffin-embedded placental specimens (control placentas, n = 9; accreta, n = 6; increta, n = 10; percreta, n = 15). The pattern of extravillous trophoblast (EVT) cell morphology was distinctive in creta placentas: densely-compacted cell columns and large star-shaped cells with a typically migratory phenotype, not common among third trimester control placentas. Quantification revealed higher CR-1 immunoreactivities in accreta (P = 0.001), increta (P = 0.0002), and percreta placentas (P = 0.001) than in controls. In contrast to controls, there was a significant positive relationship between CR-1 and CK reactivity in all creta placentas (accreta, P = 0.02; increta, P = 0.0001, and percreta, P = 0.025). This study demonstrated CR-1 expression in the placental bed, its increased expression in creta placentas, and EVT cells as the main CR-1-producing cell type. Morphological examination revealed an immature and invasive trophoblast profile in creta placentas, suggesting impairment of the trophoblast differentiation pathway. These findings provide important new insights into the pathophysiology of abnormal creta placentation and its gestational consequences.
format Online
Article
Text
id pubmed-4140153
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-41401532014-08-27 Tumorigenic Factor CRIPTO-1 Is Immunolocalized in Extravillous Cytotrophoblast in Placenta Creta Bandeira, Carla Letícia Urban Borbely, Alexandre Pulcineli Vieira Francisco, Rossana Schultz, Regina Zugaib, Marcelo Bevilacqua, Estela Biomed Res Int Research Article CRIPTO-(CR)1 is a protein associated with tumorigenesis and metastasis. Here we demonstrate that CR-1 expression in normal and creta placentas is associated with various degrees of uterine invasion. Cytokeratin (CK) and CR-1 protein expression was visualized by immunohistochemical staining of formalin-fixed, paraffin-embedded placental specimens (control placentas, n = 9; accreta, n = 6; increta, n = 10; percreta, n = 15). The pattern of extravillous trophoblast (EVT) cell morphology was distinctive in creta placentas: densely-compacted cell columns and large star-shaped cells with a typically migratory phenotype, not common among third trimester control placentas. Quantification revealed higher CR-1 immunoreactivities in accreta (P = 0.001), increta (P = 0.0002), and percreta placentas (P = 0.001) than in controls. In contrast to controls, there was a significant positive relationship between CR-1 and CK reactivity in all creta placentas (accreta, P = 0.02; increta, P = 0.0001, and percreta, P = 0.025). This study demonstrated CR-1 expression in the placental bed, its increased expression in creta placentas, and EVT cells as the main CR-1-producing cell type. Morphological examination revealed an immature and invasive trophoblast profile in creta placentas, suggesting impairment of the trophoblast differentiation pathway. These findings provide important new insights into the pathophysiology of abnormal creta placentation and its gestational consequences. Hindawi Publishing Corporation 2014 2014-08-06 /pmc/articles/PMC4140153/ /pubmed/25165718 http://dx.doi.org/10.1155/2014/892856 Text en Copyright © 2014 Carla Letícia Bandeira et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Bandeira, Carla Letícia
Urban Borbely, Alexandre
Pulcineli Vieira Francisco, Rossana
Schultz, Regina
Zugaib, Marcelo
Bevilacqua, Estela
Tumorigenic Factor CRIPTO-1 Is Immunolocalized in Extravillous Cytotrophoblast in Placenta Creta
title Tumorigenic Factor CRIPTO-1 Is Immunolocalized in Extravillous Cytotrophoblast in Placenta Creta
title_full Tumorigenic Factor CRIPTO-1 Is Immunolocalized in Extravillous Cytotrophoblast in Placenta Creta
title_fullStr Tumorigenic Factor CRIPTO-1 Is Immunolocalized in Extravillous Cytotrophoblast in Placenta Creta
title_full_unstemmed Tumorigenic Factor CRIPTO-1 Is Immunolocalized in Extravillous Cytotrophoblast in Placenta Creta
title_short Tumorigenic Factor CRIPTO-1 Is Immunolocalized in Extravillous Cytotrophoblast in Placenta Creta
title_sort tumorigenic factor cripto-1 is immunolocalized in extravillous cytotrophoblast in placenta creta
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4140153/
https://www.ncbi.nlm.nih.gov/pubmed/25165718
http://dx.doi.org/10.1155/2014/892856
work_keys_str_mv AT bandeiracarlaleticia tumorigenicfactorcripto1isimmunolocalizedinextravillouscytotrophoblastinplacentacreta
AT urbanborbelyalexandre tumorigenicfactorcripto1isimmunolocalizedinextravillouscytotrophoblastinplacentacreta
AT pulcinelivieirafranciscorossana tumorigenicfactorcripto1isimmunolocalizedinextravillouscytotrophoblastinplacentacreta
AT schultzregina tumorigenicfactorcripto1isimmunolocalizedinextravillouscytotrophoblastinplacentacreta
AT zugaibmarcelo tumorigenicfactorcripto1isimmunolocalizedinextravillouscytotrophoblastinplacentacreta
AT bevilacquaestela tumorigenicfactorcripto1isimmunolocalizedinextravillouscytotrophoblastinplacentacreta